论文信息 - Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II study - 字舞流文

Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II study

I. Bondarenko | T. Eisen | Y. Shparyk | Claudia Dallinger | M. Studeny | N. MacLeod | Robert R Jones | G. Wallenstein | Y. Khder | G. Temple | A. Loembé | Robert Jones